(Q45755644)

English

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

scientific article published in June 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Chayama K

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Suzuki Y

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Kobayashi M

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Kobayashi M

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Tsubota A

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Hashimoto M

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Miyano Y

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Koike H

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Kobayashi M

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Koida I

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Arase Y

11

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Saitoh S

12

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Murashima N

13

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Ikeda K

14

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Kumada H

15

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

27

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

1711-1716

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro evaluation of combination therapies against hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapies for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of lamivudine resistance by HBV

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Tbe complete nudeotide sequences of the cloned hepatitis B vims DNA; subtype adr and adw

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270634

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510270634

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9620347

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45755644&oldid=2081041874"